+958.0%
MRNA vs XRT
+127.6%
+830.4%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | XRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +2.3% | -7.1% | -6.1% |
| 7D | -20.9% | -2.2% | -18.6% | -19.9% |
| 30D | -13.3% | +4.0% | -17.3% | -15.1% |
| 3M | +212.6% | +3.9% | +208.7% | +209.5% |
| 6M | +309.0% | +13.9% | +295.1% | +287.1% |
| YTD | +567.3% | +6.6% | +560.7% | +553.3% |
| 1Y | +689.7% | +15.8% | +673.9% | +645.9% |
| 3Y | +157.4% | +47.9% | +109.5% | +124.9% |
| 5Y | -21.7% | -5.8% | -15.9% | -27.7% |
| All | +958.0% | +127.6% | +830.4% | +1,021.9% |
Cumulative growth
Daily Returns
Daily percentage return beside XRT.
Daily Out/Under-Performance
Portfolio return minus XRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded XRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling